Ignite Creation Date:
2024-05-05 @ 9:52 PM
Last Modification Date:
2024-10-26 @ 10:11 AM
Study NCT ID:
NCT00987792
Status:
COMPLETED
Last Update Posted:
2015-08-07
First Post:
2009-09-30
Brief Title:
CAPRIVI Community Acquired Pneumonia Treatment With Avelox in Hospitalized Patients
Sponsor:
Bayer
Organization:
Bayer
Study Overview
Official Title:
CAPRIVI Community Acquired Pneumonia Treatment With Avelox in Hospitalized Patients
Status:
COMPLETED
Status Verified Date:
2015-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to obtain data from hospitalized Community Acquired Pneumonia CAP patients on the disease including disease severity clinical signs and symptoms and measures used for diagnosis in daily routine practice as well as data on Avelox including information on the use effectiveness treatment outcome safety and tolerability
As this is a non-interventional observational study routine clinical practice is observed The application of medications follows the normal routines and is decided by the treating physician under recognition of the package insert
As this is a non-interventional observational study routine clinical practice is observed The application of medications follows the normal routines and is decided by the treating physician under recognition of the package insert
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| AX0801 | OTHER | Company internal | None |